IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Today’s Receipts
Public-record receiptR-FLOfficial filing linked

Byron Donalds disclosed SELL $FDS

Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.

Trade range
$1K – $15K
Filed
2025-03-25
Trade date
2025-02-13
Disclosure lag
40 days after trade

Why this receipt matters

A quick read before you share it.

These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.

Official public filing linked
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 40 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
43 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Byron Donalds, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 2 lobbying filings.

Source

Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20027903 · filed 2025-03-25 · disclosed 40d after transaction

Market context

FDS

Vs SPY: -63.8%

Factual flags

  • 2 lobbying filings linked to this ticker.
  • 3 nearby same-ticker disclosures in the surrounding 30-day window.
  • 4 trades filed on 2025-03-25 (batch dump)

Member trail

Byron Donalds

U.S. House · FL-19

House Committee on Oversight and Government ReformHouse Committee on Financial Services

Ticker trail

$FDS

Company metadata pending

Follow this ticker

Alert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.